GenoScreen
PrivateLast Round
Early Funding
Dec 1, 2021
Total Funding Raised
$2.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GenoScreen is a biotechnology company that provides genomic information services, including DNA sequencing, genotyping, and bioinformatics analysis for research and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoScreen Comparables
Compare GenoScreen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bioMérieux | 82% | |
| AbL Diagnostics SA | 79% | |
| Biotia | 77% | |
GenoScreen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 1, 2021 | ||||
| Early Funding | Jan 28, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 37% MoM.
- Jul 6, 2025
Monthly visitors grew 41% MoM, reaching 2.4K.
GenoScreen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenoScreen's valuation, stock price, and market status.